MYCN and neuroblastoma: Morretta et al. applied optimized drug affinity-responsive target stability (DARTS) based proteomics using in situ digestion and LC-MS/MS experiments [142,143] to investigate the effects of STIRUR 41 on HTLA-230, a stage-IV NB cell line with MYCN amplification [134].